First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the α-tropomyosin gene

Radiology

Volumn 226, Issue 1, 2003, Pages 129-137

  Sipola, Petri ^a   Lauerma, Kirsi ^d   Husso Saastamoinen, Minna ^a   Kuikka, Jyrki T ^a,b   Vanninen, Esko ^a   Laitinen, Tomi ^a   Manninen, Hannu ^a   Niemi, Pekka ^c   Peuhkurinen, Keijo ^a   Jääskeläinen, Pertti ^a   Laakso, Markku ^a   Kuusisto, Johanna ^a   Aronen, Hannu J ^a,d  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Niuvanniemen sairaala   (Finland)

^c Universität Turku   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Genes and genetics; Heart, cardiomyopathy; Heart, hypertrophy; Heart, MR; Heart, perfusion; Magnetic resonance (MR), perfusion study

Indexed keywords

ALPHA TROPOMYOSIN; ASPARAGINE; ASPARTIC ACID; GADOLINIUM PENTETATE MEGLUMINE; GENE PRODUCT; TROPOMYOSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRST PASS EFFECT; GENE MUTATION; HEART LEFT VENTRICLE WALL; HEART PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REST; SIGNAL PROCESSING; STRESS;

ADENOSINE; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ANGIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PERFUSION; REPRODUCIBILITY OF RESULTS; TROPOMYOSIN;

EID: 0037254355     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2261011874     Document Type: Article

References (35)

1. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997; 204:373-384.
2. Lauerma K, Virtanen KS, Sipilä LM, Hekali P, Aronen HJ. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997; 96:2859-2867.
3. Cullen JH, Horsfield MA, Reek CR, et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999; 33:1386-1394.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995; 92:1680-1692.
5. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350:127-133.
6. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336:775-785.
7. O'Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987; 76:1214-1223.
8. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
9. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991; 17:879-886.
10. Tadamura E, Yoshibayashi M, Yonemura T, et al. Significant regional heterogeneity of coronary flow reserve in paediatric hypertrophic cardiomyopathy. Eur J Nucl Med 2000; 27:1340-1348.
11. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985; 71:234-243.
12. Memmola C, Iliceto S, Napoli VF, et al. Coronary flow dynamics and reserve assessed by transesophageal echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1994; 74:1147-1151.
13. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999; 211: 129-135.
14. Grover-McKay M, Schwaiger M, Krivokapich J, et al. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13:317-324.
15. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987; 163:697-702.
16. Park JH, Kim YM, Chung JW, et al. MR imaging of hypertrophic cardiomyopathy. Radiology 1992; 185:441-446.
17. Allison JD, Flickinger FW, Wright JC, et al. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography. Magn Reson Imaging 1993; 11:329-334.
18. Pons-Llado G, Carreras F, Borras X, et al. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 1997; 79:1651-1656.
19. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 1999; 72:258-264.
20. Jääskeläinen P, Soranta M, Miettinen R, et al. The cardiac b-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 1998; 32:1709-1716.
21. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997; 77:130-132.
22. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332:1058-1064.
23. Coviello DA, Maron BJ, Spirito P, et al. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol 1997; 29:635-640.
24. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
25. Frahm J, Haase A, Matthaei D. Rapid NMR imaging of dynamic processes using the FLASH technique. Magn Reson Med 1986; 3:321-327.
26. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987; 163:697-702.
27. Sakuma H, Fujita N, Foo TK, et al. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology 1993; 188:377-380.
28. Katz J, Milliken MC, Stray-Gundersen J, et al. Estimation of human myocardial mass with MR imaging. Radiology 1988; 169: 495-498.
29. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993; 29:485-497.
30. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000; 101:1379-1383.
31. Schmiedl U, Moseley ME, Ogan MD, Chew WM, Brasch RC. Comparison of initial biodistribution patterns of Gd-DTPA and albumin-(Gd-DTPA) using rapid spin echo MR imaging. J Comput Assist Tomogr 1987; 11:306-313.
32. Van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991; 9:313-321.
33. Posma JL, Blanksma PK, van der Wall EE, et al. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. Am Heart J 1996; 132:1020-1027.
34. Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death. N Engl J Med 1998; 339:1201-1209.
35. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.